Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research Progress on Alzheimer's Disease and Resveratrol
Yan Yan, Huihuang Yang, Yuxun Xie, et al.
Neurochemical Research (2020) Vol. 45, Iss. 5, pp. 989-1006
Closed Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases
Fangzhou Jiao, Zuojiong Gong
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-19
Open Access | Times Cited: 226
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Angelica Varesi, Elisa Pierella, Marcello Romeo, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 668-668
Open Access | Times Cited: 166
The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
Ya-Shuo Feng, Zixuan Tan, Linyu Wu, et al.
Ageing Research Reviews (2020) Vol. 64, pp. 101192-101192
Closed Access | Times Cited: 148
Resveratrol and Neuroprotection: Impact and Its Therapeutic Potential in Alzheimer's Disease
Md. Habibur Rahman, Rokeya Akter, Tanima Bhattacharya, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 140
Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease
Germán Plascencia‐Villa, George Perry
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1628-1628
Open Access | Times Cited: 58
Advancements in autophagy perturbations in Alzheimer’s disease: Molecular aspects and therapeutics
Rishika Dhapola, Sneha Kumari, Prajjwal Sharma, et al.
Brain Research (2025) Vol. 1851, pp. 149494-149494
Closed Access | Times Cited: 3
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
Jiaojiao Wu, Yang Yu, Yan Wan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113207-113207
Open Access | Times Cited: 68
Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer’s disease from bench to bedside
Fahadul Islam, Mohamed H. Nafady, Md. Rezaul Islam, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 7, pp. 4384-4404
Closed Access | Times Cited: 58
Resveratrol: A potential therapeutic natural polyphenol for neurodegenerative diseases associated with mitochondrial dysfunction
Ekta Yadav, Pankajkumar Yadav, Mohd Masih Uzzaman Khan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 44
Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
Nicola Marrano, Giuseppina Biondi, Anna Borrelli, et al.
Biomolecules (2023) Vol. 13, Iss. 1, pp. 183-183
Open Access | Times Cited: 25
Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation
Mingming Zhang, Zhiyin Tang
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114474-114474
Open Access | Times Cited: 25
The Role of Sirtuin 1 in Ageing and Neurodegenerative Disease: A Molecular Perspective
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102545-102545
Closed Access | Times Cited: 10
Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
Alex Yang, Ahmed Bagit, Rebecca E. K. MacPherson
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4628-4628
Open Access | Times Cited: 55
Role of Hydrogen Sulfide and Polysulfides in Neurological Diseases: Focus on Protein S-Persulfidation
Hai‐Jian Sun, Zhiyuan Wu, Xiaowei Nie, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 6, pp. 868-884
Open Access | Times Cited: 51
Neuroprotective Effect of Trans-Resveratrol in Mild to Moderate Alzheimer Disease: A Randomized, Double-Blind Trial
Jiachen Gu, Zongshan Li, Huimin Chen, et al.
Neurology and Therapy (2021) Vol. 10, Iss. 2, pp. 905-917
Open Access | Times Cited: 46
Nanoparticles Loaded with Docetaxel and Resveratrol as an Advanced Tool for Cancer Therapy
Magdalena Jurczyk, Janusz Kasperczyk, Dorota Wrześniok, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1187-1187
Open Access | Times Cited: 37
Quarter-Century Explorations of Bioactive Polyphenols: Diverse Health Benefits
Arthur J. Chu
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 31
The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease
Xiao‐Lan Liu, Meng Ye, Liang Ma
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 29
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases
Sanaz Keshavarz Shahbaz, Khadije Koushki, Samaneh Keshavarz Hedayati, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 6, pp. 2793-2824
Closed Access | Times Cited: 7
Ginkgolide B inactivates the NLRP3 inflammasome by promoting autophagic degradation to improve learning and memory impairment in Alzheimer’s disease
Shao Li, Dong Chen, Deqin Geng, et al.
Metabolic Brain Disease (2022) Vol. 37, Iss. 2, pp. 329-341
Closed Access | Times Cited: 28
Hub Genes, Diagnostic Model, and Predicted Drugs Related to Iron Metabolism in Alzheimer's Disease
Xuefeng Gu, Donglin Lai, Shuang Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 27
Neurobehavioral impairments from chromium exposure: Insights from a zebrafish model and drug validation
Seenivasan Boopathi, B. Haridevamuthu, Akash Gandhi, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2023) Vol. 275, pp. 109780-109780
Closed Access | Times Cited: 13
Curcumin hybrid molecules for the treatment of Alzheimer's disease: Structure and pharmacological activities
Wei-Biao Zang, Huiling Wei, Weiwei Zhang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116070-116070
Closed Access | Times Cited: 13
Non-food bioactive product (+)-nootkatone: Chemistry and biological activities
Jiangping Fan, Zhiyan Liu, Shengnan Xu, et al.
Industrial Crops and Products (2022) Vol. 177, pp. 114490-114490
Closed Access | Times Cited: 20
An insight into the concept of neuroinflammation and neurodegeneration in Alzheimer’s disease: targeting molecular approach Nrf2, NF-κB, and CREB
Shaveta Bhardwaj, Amarjot Kaur Grewal, Shamsher Singh, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 2943-2960
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top